Fortress Biotech, Inc. (FBIO): Nasdaq/NYSE listing notice — Fortress Biotech gets second 180-day Nasdaq bid-price compliance extension to Oct 30, 2023

Fortress Biotech, Inc.

Nasdaq granted second 180-day grace period under Listing Rule 5810(c)(3)(A)(ii) on May 2, 2023.
Company must demonstrate closing bid above $1.00 for 10 consecutive days by October 30, 2023.
If noncompliant by deadline, Nasdaq will issue delisting notice; company may appeal to Hearings Panel.
Common stock (FBIO) and preferred stock (FBIOP) continue trading on Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Fortress Biotech, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(ii)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)(ii)

Exact text from the filing

May 2, 2023, in accordance with Nasdaq Listing Rule 5810(c)(3)(A)(ii), the Staff granted the Company a second 180-calendar day grace period to regain compliance with the Rule. The Company intends to closely monitor the closing bid price for its Common Stock and consider all available options to remedy the bid price deficiency. In the event the Company is not able to demonstrate compliance with the Rule by October 30, 2023, the Staff will provide written notification that the Company’s Common Stock is subject to delisting, which the Company may appeal. The Company’s appeal request would stay an

View on SEC.gov

Browse all listing & compliance notices →

Fortress Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-008300

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.